05.23.23 -- New FDA Framework: Use Of Digital Health Tech In Drug Development

In March 2023, CDER and CBER published Framework for the Use of Digital Health Technologies (DHTs) in Drug and Biological Product Development (the “Framework”) to “guide the use of DHT-derived data in regulatory decision-making for drugs and biological products.” Here is what you need to know.

Efficiencies in ophthalmology studies can be improved in a variety of ways. Learn how technology can help researchers to accelerate the pace of research, improve the quality of data, and reduce costs.

A global Top 10 pharma sponsor needed a provider whose core focus was on patient payments with heightened functionality and centrality. Find out the solution they turned to in order to solve this need.

Read about perfusion imaging techniques and their use for clinical trials, with a particular focus on perfusion imaging using DCE-MRI.

In an ideal scenario, the eTMF would operate like a well-oiled factory. Examine some of the factors that would support making “The eTMF Factory” a reality.

IQVIA Asset Maximizer is a comprehensive suite of solutions that intelligently connects insights, technology, and expertise to maximize your asset's probability of success in a complex and competitive environment.

With Medrio's combination of technology and consultative support from our team of experts, you can experience a seamless ePRO transition and establish a smoother path to regulatory submission.